Neurochemical metabolites in prefrontal cortex in patients with mild/moderate levels in first-episode depression

Neuropsychiatric Disease and Treatment

Volumn 9, Issue , 2013, Pages 1053-1059

  Sözeri Varma, Gülfizar ^a   Kalkan Oǧuzhanoglu, Nalan ^a   Efe, Muharrem ^a   Kiroglu, Yilmaz ^a   Duman, Taçlan ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Choline; Creatine; Magnetic resonance spectroscopy; Major depressive disorder; N acetyl aspartate

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DSM-IV; ENZYME BLOOD LEVEL; FEMALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; NEUROLOGIC EXAMINATION; PREFRONTAL CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 84881514708     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S42627     Document Type: Article

References (39)

1. Hastings RS, Parsey RV, Oquendo MA, Arango V, Mann JJ. Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology. 2004;29:952-959.
2. Zou K, Deng W, Li T, et al. Changes of brain morphometry in first-episode, drug-naïve, non-late-life adult patients with major depression: an optimized voxel-based morphometry study. Biol Psychiatry. 2010;67:186-188.
3. Malykhin NV, Carter R, Hegadoren KM, Seres P, Coupland NJ. Fronto-limbic volumetric changes in major depressive disorder. J Affect Disord. 2012;136:1104-1113.
4. Rajkowska G, Miguel-Hidalgo JJ, Wei J, et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry. 1999;45:1085-1098.
5. Narita H, Odawara T, Iseki E, Kosaka K, Hirayasu Y. Psychomotor retardation correlates with frontal hypoperfusion and the Modified Stroop Test in patients under 60-years-old with major depression. Psychiatry Clin Neurosci. 2004;58:389-395.
6. Oh DH, Son H, Hwang S, Kim SH. Neuropathological abnormalities of astrocytes, GABAergic neurons, and pyramidal neurons in the dorsolateral prefrontal cortices of patients with major depressive disorder. Eur Neuropsychopharmacol. 2012;22:330-338.
7. Lorenzetti V, Allen NB, Fornito A, Yücel M. Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J Affect Disord. 2009;117:1-17.
8. Arnone D, McIntosh AM, Ebmeier KP, Munafò MR, Anderson IM. Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses. Eur Neuropsychopharmacol. 2012;22:1-16.
9. Yildiz-Yeşiloǧlu A, Ankerst DP. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:969-995.
10. Monkul ES, Yildiz S, Soares JC. Magnetic resonance spectroscopy (MRS) applications in bipolar disorder. Turk Psikiyatri Derg. 2004;15: 138-147.
11. Phillips ML, Ladouceur CD, Drevets WC. A Neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry. 2008;13:833-857.
12. Michael N, Erfurth A, Ohrmann P, Arolt V, Heindel W, Pfleiderer B. Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychol Med. 2003;33:1277-1284.
13. 1H-MRS at 3 T. Invest Radiol. 2003;38:403-408.
14. Coupland NJ, Ogilvie CJ, Hegadoren KM, Seres P, Hanstock CC, Allen PS. Decreased prefrontal Myo-inositol in major depressive disorder. Biol Psychiatry. 2005;57:1526-1534.
15. Binesh, N, Kumar A, Hwang S, Mintz J, Thomas, MA. Neurochemistry of late-life depression: a pilot two-dimensional MR spectroscopic study. J Magn Reson Imaging. 2004;20:1039-1045.
16. Grachev ID, Ramachandran TS, Thomas PS, Szeverenyi NM, Fredrickson BE. Association between dorsolateral prefrontal n-acetyl aspartate and depression in chronic back pain: an in vivo proton magnetic resonance spectroscopy study. J Neural Transm. 2003;110:287-312.
17. Milne A, Macqueen GM, Yucel K, Soreni N, Hall GB. Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder: a proton magnetic resonance spectroscopy study. Neuroimage. 2009;47:36-41.
18. 1H-Magnetic resonance spectroscopy study of dorsolateral prefrontal cortex in unipolar mood disorder patients. Psychiatry Res. 2005;138:131-139.
19. Gönül AS, Kitis O, Ozan E, et al. The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:120-125.
20. Horn DI, Yu C, Steiner J, et al. Glutamatergic and resting-state functional connectivity correlates of severity in major depression - the role of pregenual anterior cingulate cortex and anterior insula. Front Syst Neurosci. 2010;4:1-10.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
22. Hamilton MA. Rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
23. Akdemir A, Türkçapar MH, Örsel SD, Demirergi N, Dag I, Ozbay MH. Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale. Compr Psychiatry. 2001;42:161-165.
24. Kienlin von M. The basics of magnetic resonance spectroscopy. In:Methodology, spectroscopy and clinical MRI.15th Annual Scientific Meeting 1998;3-7.
25. Klose U. Measurement sequences for single voxel proton MR spectroscopy. Eur J Radiol. 2008;67:194-201.
26. Kaymak SU, Demir B, Oǧuz KK, Sentürk S, Uluǧ B. Antidepressant effect detected on proton magnetic resonance spectroscopy in drugnaïve female patients with first-episode major depression. Psychiatry Clin Neurosci. 2009;63:350-356.
27. Auer DP, Pütz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 2000;47:305-313.
28. Nery FG, Stanley JA, Chen HH, et al. Normal metabolite levels in the left dorsolateral prefrontal cortex of unmedicated major depressive disorder patients: a single voxel (1) H spectroscopy study. Psychiatry Res. 2009;30:177-183.
29. Wang Y, Jia Y, Xu G, Ling X, Liu S, Huang L. Frontal white matter biochemical abnormalities in first-episode, treatment-naive patients with major depressive disorder: A proton magnetic resonance spectroscopy study. J Affect Disord. 2012;136:620-626.
30. Portella MJ, de Diego-Adeliño J, Gómez-Ansón B et al. Ventromedial prefrontal spectroscopic abnormalities over the course of depression: a comparison among first episode, remitted recurrent and chronic patients. J Psychiatr Res. 2011;45:427-434.
31. Steingard RJ, Yurgelun-Todd DA, Hennen J, et al. Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biol Psychiatry. 2000;48:1053-1061.
32. Farchione TR, Moore GJ, Rosenberg DR. Proton magnetic resonance spectroscopic imaging in pediatric major depression. Biol Psychiatry. 2002;52:86-92.
33. Olvera RL, Caetano SC, Stanley JA, et al. Reduced medial prefrontal N-acetyl-aspartate levels in pediatric major depressive disorder: a multivoxel in vivo (1)H spectroscopy study. Psychiatry Res. 2010;184: 71-76.
34. Caetano SC, Fonseca M, Olvera RL, et al. Proton spectroscopy study of left dorsolateral prefrontal cortex in pediatric depressed patients. Neurosci Lett. 2005;384:321-326.
35. Henigsberg N, Bajs M, Hrabac P, et al. Changes in brain metabolites measured with magnetic resonance spectroscopy in antidepressant responders with comorbid major depression and posttraumatic stress disorder. Coll Antropol. 2011;35(Suppl 1):145-148.
36. Chen CS, Chiang IC, Li CW, et al. Proton magnetic resonance spectroscopy of late-life major depressive disorder. Psychiatry Res. 2009;172:210-214.
37. Kumar A, Thomas A, Lavretsky H, et al. Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am J Psychiatry. 2002;159:630-636.
38. Holtzheimer PE, Mayberg HS. Neuropsychiatric aspects of mood disorders. In:Yudofsky SC, Hales RE, editors. The American Psychiatric Publishing Textbook of Neuropsychiatry and behavioral Neurosciences. Fifth Edition, Washington DC. 2008.
39. Fossati P, Ergis AM, Allilaire JF. Executive functioning in unipolar depression: a review. Encephale. 2002;28:97-107.